Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
348,143
-
Shares change
-
-18,967
-
Total reported value, excl. options
-
$887,987
-
Value change
-
-$63,874
-
Number of buys
-
8
-
Number of sells
-
-6
-
Price
-
$2.55
Significant Holders of Predictive Oncology Inc. - COM (POAI) as of Q1 2024
17 filings reported holding POAI - Predictive Oncology Inc. - COM as of Q1 2024.
Predictive Oncology Inc. - COM (POAI) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 348,143 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (143,518 shares), RAYMOND JAMES & ASSOCIATES (120,807 shares), GEODE CAPITAL MANAGEMENT, LLC (37,583 shares), RENAISSANCE TECHNOLOGIES LLC (17,176 shares), STATE STREET CORP (13,837 shares), CARNEGIE MELLON UNIVERSITY (10,358 shares), Tower Research Capital LLC (TRC) (2,685 shares), UBS Group AG (1,263 shares), OSAIC HOLDINGS, INC. (475 shares), and PSI Advisors, LLC (399 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.